Kathy Boltz, PhD, Author at Oncology Nurse Advisor https://www.oncologynurseadvisor.com Sat, 05 Jan 2019 00:14:25 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png Kathy Boltz, PhD, Author at Oncology Nurse Advisor https://www.oncologynurseadvisor.com 32 32 Weight Loss Through Diet Improves Risks for Cancer in Overweight/Obese Women https://www.oncologynurseadvisor.com/home/cancer-types/breast-cancer/weight-loss-through-diet-improves-risks-for-cancer-in-overweight-obese-women/ Tue, 16 Aug 2016 19:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/weight-loss-through-diet-improves-risks-for-cancer-in-overweight-obese-women/ Losing weight through diet or diet and exercise improves risk for cancer in overweight or obese postmenopausal women. Although exercise alone can help maintain weight loss, it is not as effective as diet and exercise.]]> Technique Maps Biomarkers That Predict Immunotherapy Response https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/technique-maps-biomarkers-that-predict-immunotherapy-response/ Mon, 15 Aug 2016 14:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/technique-maps-biomarkers-that-predict-immunotherapy-response/ With only 1 slide of a tumor section, an analysis of multiple tumor markers can be performed. The technique may help predict response to immunotherapy, which typically evokes responses in only a small group of patients.]]> Novel Pathway Improves Access to Genetic Testing for Women With Ovarian Cancer https://www.oncologynurseadvisor.com/home/cancer-types/ovarian-cancer/novel-pathway-improves-access-to-genetic-testing-for-women-with-ovarian-cancer/ Fri, 12 Aug 2016 14:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/novel-pathway-improves-access-to-genetic-testing-for-women-with-ovarian-cancer/ Rapid, robust, and affordable genetic testing for patients with ovarian cancer that allows a much larger portion of patients to benefit from personalized cancer management and their relatives to benefit from preventive strategies can be achieved.]]> Ipilumumab Feasible for Recurrent Hematologic Cancers After Allogeneic Stem Cell Transplant https://www.oncologynurseadvisor.com/home/cancer-types/leukemia/ipilumumab-feasible-for-recurrent-hematologic-cancers-after-allogeneic-stem-cell-transplant/ Tue, 09 Aug 2016 15:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/ipilumumab-feasible-for-recurrent-hematologic-cancers-after-allogeneic-stem-cell-transplant/ Magnified stem cellsRepeat doses of ipilimumab can restore a complete remission in patients with advanced blood cancers who relapse after allogeneic hematopoietic stem cell transplant (alloHSCT).]]> Increasing Weight Associated With Disease Progression in Multiple Myeloma https://www.oncologynurseadvisor.com/home/cancer-types/multiple-myeloma/increasing-weight-associated-with-disease-progression-in-multiple-myeloma/ Mon, 08 Aug 2016 15:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/increasing-weight-associated-with-disease-progression-in-multiple-myeloma/ Increasing body mass index (BMI) allows growth and progression of disease in patients with multiple myeloma, a recently published study has shown.]]> Some Gene Variants Increase the Risk for Melanoma in People With Red Hair, Freckling https://www.oncologynurseadvisor.com/home/cancer-types/melanoma/some-gene-variants-increase-the-risk-for-melanoma-in-people-with-red-hair-freckling/ Fri, 05 Aug 2016 17:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/some-gene-variants-increase-the-risk-for-melanoma-in-people-with-red-hair-freckling/ Variants of the MC1R gene, associated with red hair, pale skin, and freckles, increases the number of genetic mutations related to skin cancer and the level of other gene mutations, further increasing the risk for skin cancer.]]> Anti-HER2 Therapies Link With Heart Blood Vessel Development Explains Cardiovascular Side Effects of Trastuzumab https://www.oncologynurseadvisor.com/home/cancer-types/breast-cancer/anti-her2-therapies-link-with-heart-blood-vessel-development-explains-cardiovascular-side-effects-of-trastuzumab/ Wed, 03 Aug 2016 15:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/anti-her2-therapies-link-with-heart-blood-vessel-development-explains-cardiovascular-side-effects-of-trastuzumab/ Therapies targeting ErbB2 (HER2), such as trastuzumab (Herceptin), are often associated with cardiovascular side effects. ErbB2 was recently found to also be expressed by vascular endothelial cells, and is an example of how tissue growth and blood vessel patterning are integrated at the molecular level.]]> Adjuvant Therapy Improves Survival in Stage II Colon Cancer, Study Confirms https://www.oncologynurseadvisor.com/home/cancer-types/colorectal-cancer/adjuvant-therapy-improves-survival-in-stage-ii-colon-cancer-study-confirms/ Fri, 29 Jul 2016 16:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/adjuvant-therapy-improves-survival-in-stage-ii-colon-cancer-study-confirms/ Hybrid Immune Cells Have Antitumor Effects in Early Stage Lung Cancer https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/hybrid-immune-cells-have-antitumor-effects-in-early-stage-lung-cancer/ Fri, 29 Jul 2016 14:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/hybrid-immune-cells-have-antitumor-effects-in-early-stage-lung-cancer/ Enlarged blood cellsA subset of tumor-associated neutrophils (TANs) has hybrid characteristics of both neutrophils and antigen-presenting cells in samples from early stage human lung cancers.]]> Clinician Communication, Adherence to Protocols, and Presence of Pharmacists Improve Outcomes in ICUs https://www.oncologynurseadvisor.com/home/hot-topics/side-effect-management/clinician-communication-adherence-to-protocols-and-presence-of-pharmacists-improve-outcomes-in-icus/ Thu, 28 Jul 2016 18:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/clinician-communication-adherence-to-protocols-and-presence-of-pharmacists-improve-outcomes-in-icus/ Oncologic patients are among the main users of ICUs and are vulnerable to infections and adverse drug reactions. However, relatively simple processes of organization can reduce the risk of these problems.]]>